Skip to main content
Equibles
ELTX logo

ELTX · Elicio Therapeutics, Inc. · Analyst Estimates

Track ELTX — free

Use ELTX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ELTX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$2.05 -0.06 (-2.84%) At close · Sep 11
Russell 2000 member Rebalance outlook locked
Going-concern doubt — flagged Aug 13, 2026

Substantial doubt about the company's ability to continue as a going concern.

“We are currently facing substantial doubt about our ability to continue as a going concern, given our cash position and cash runway.”
View the 10-Q filed Aug 13, 2026
Market Cap
$53.88M
Shares
26.28M

Analyst Estimates

Compare analyst forecasts for Elicio Therapeutics, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Only independently verified consensus published through the company's investor-relations sources is available.

Consensus not yet available

Only independently verified consensus published through the company's investor-relations sources is available.

Key facts CIK 1601485 CUSIP 28657F103 13F (30d) 19 filings 19 filers Visit website Investor relations